Colorectal Cancer Coverage from Every Angle
Advertisement
Advertisement

Alan P. Venook, MD, on Novel Agents in Metastatic Colorectal Cancer

Posted: Friday, March 22, 2019

Alan P. Venook, MD, of the University of California, San Francisco, discusses the status of regimens that include irinotecan, cetuximab, vemurafenib, panitumumab, and encorafenib in the treatment of BRAF V600E–mutated colorectal tumors.



By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.